Articles in section Research & Development
| << Opinion & Analysis | 476 articles | Royalties >> |
| Pages 1 2 3 4 5 .. 48 | Next >> |
-
Johnson & Johnson Pays Sail Biomedicines US$785M Upfront to Develop In Vivo CAR-T Therapies for Autoimmune Disease
-
Vertex Signs Multispecific T-Cell Engager Collaboration with AbCellera for Autoimmune Diseases
-
AstraZeneca Signs US$1.77 B Renal Disease Licensing Pact with CSPC Pharmaceutical Group
-
Bristol Myers Squibb Signs US$15.2 B Licensing Pact with Hengrui Pharma for Medicines Across Oncology, Haematology, and Immunology
-
Regeneron and Telix Pharmaceuticals Sign US$4.3 B Radiopharmaceutical Oncology Deal
-
Merck & Co. Inks US$2.2 B IBD Target Discovery Collaboration with Quotient Therapeutics
-
Lilly Signs US$8.85 B Oncology and Immunology Partnership with Innovent Biologics
-
AstraZeneca Signs US$18.5 B Licensing Pact with CSPC Pharmaceutical Group for Obesity and Type 2 Diabetes Treatments
-
Lilly Signs US$1.9 B Global Collaboration with Repertoire for Autoimmune Diseases
-
Boehringer Ingelheim and Simcere Forge US$1.26 B Collaboration to Advance Inflammatory Bowel Disease Bispecific Antibody
PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.
RSS